|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
JSTOR_on1029759751 |
003 |
OCoLC |
005 |
20231005004200.0 |
006 |
m o d |
007 |
cr cnu|||unuuu |
008 |
180329s2018 nju ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d N$T
|d YDX
|d JSTOR
|d EBLCP
|d P@U
|d OCLCF
|d OCLCQ
|d K6U
|d UX1
|d OCLCQ
|d OCLCO
|d LUU
|d OCLCQ
|
019 |
|
|
|a 1175641067
|
020 |
|
|
|a 9780813586434
|q (electronic bk.)
|
020 |
|
|
|a 0813586437
|q (electronic bk.)
|
020 |
|
|
|a 0813586410
|
020 |
|
|
|a 9780813586410
|
020 |
|
|
|z 9780813586410
|
035 |
|
|
|a (OCoLC)1029759751
|z (OCoLC)1175641067
|
037 |
|
|
|a 22573/ctt1q0fh1t
|b JSTOR
|
050 |
|
4 |
|a RC671
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
072 |
|
7 |
|a MED078000
|2 bisacsh
|
072 |
|
7 |
|a MED112000
|2 bisacsh
|
072 |
|
7 |
|a MED071000
|2 bisacsh
|
072 |
|
7 |
|a MED014000
|2 bisacsh
|
072 |
|
7 |
|a MED010000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.106
|2 23
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Iatrogenicity :
|b Causes and Consequences of Iatrogenesis in Cardiovascular Medicine /
|c edited by Ihor B. Gussak and John B. Kostis ; co-edited by Ibrahim Akin [and five others].
|
264 |
|
1 |
|a New Brunswick, New Jersey :
|b Rutgers University Press Medicine,
|c 2018.
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
588 |
|
|
|a Online resource; title from PDF title page (EBSCO, viewed March 29, 2018).
|
504 |
|
|
|a Includes bibliographical references and index.
|
520 |
|
|
|a "Iatrogenesis is the occurrence of untoward effects resulting from actions of health care providers, including medical errors, medical malpractice, practicing beyond one's expertise, adverse effects of medication, unnecessary treatment, inappropriate screenings, and surgical errors. This is a huge public health issue: tens to hundreds of thousands of deaths are attributed to iatrogenic causes each year in the U.S., and vulnerable populations such as the elderly and minorities are particularly susceptible. Edited by two renowned cardiology experts, Iatrogenicity: Causes and Consequences of Iatrogenesis in Cardiovascular Medicine addresses both the iatrogenicity that arises with cardiovascular interventions, as well as non-cardiovascular interventions that result in adverse consequences on the cardiovascular system. The book aims to achieve three things: to summarize the available information on this topic in a single high-yield volume; to highlight the human and financial cost of iatrogenesis; and to describe and propose potential interventions to ameliorate the effects of iatrogenesis. This accessible book is a practical reference for any practicing physician who sees patients with cardiovascular issues. ."--
|c Provided by publisher
|
505 |
0 |
|
|a Intro; Title Page; Copyright; Contents; Contributors; The Concept of Iatrogenicity; Part I: Medical Harm; Chapter 1. Iatrogenicity: Definition, History, and Modern Context; Chapter 2. Epidemiology and Public Health Aspects and Implications of Iatrogenicity: Regulatory, Legal and Ethical Dimensions; Chapter 3. Risk Management: The Medical Center Administration Perspective; Chapter 4. Iatrogenicity from the Patient's Perspective; Chapter 5. A Naturopathic Perspective on Iatrogenesis; Part II: Iatrogenicity of Cardiovascular Drugs and Cardiovascular Toxicity of Noncardiac Drugs
|
505 |
8 |
|
|a Chapter 6. Clinical Manifestations of Acute and Chronic Drug-Induced Iatrogenic Cardiovascular Diseases and SyndromesChapter 7. Drug-Induced Cardiac Arrhythmias and Sudden Cardiac Death; Chapter 8. Chemotherapy-Induced Cardiomyopathy; Chapter 9. Iatrogenicity of Blood Pressure Measurement in the Diagnosis of Hypertension; Chapter 10. Antihypertensive Drug-Induced Iatrogenic Cardiovascular Syndromes; Chapter 11. Iatrogenicity of Cardiovascular Drugs Associated With Cardiac and Noncardiac Toxicities: Antihypertensive Agents and Biologics
|
505 |
8 |
|
|a Chapter 12. Iatrogenic Aspects of Hypertension in Pregnancy: Focus on PreeclampsiaChapter 13. Women and Iatrogenic Cardiovascular Disease: Menopausal Estrogen as the Prime Suspect; Chapter 14. Iatrogenic Aspects of Lipid-Lowering, Antiplatelet, and Anticoagulant Agents; Chapter 15. Iatrogenic Effects of Urologic Drugs on the Cardiovascular System; Chapter 16. Iatrogenicity and Antianginal Drugs; Chapter 17. Antidiabetic Drugs and Cardiovascular Risk: Where Do We Stand?; Chapter 18. Cardiovascular Iatrogenicity in Older Adults
|
505 |
8 |
|
|a Part III: Iatrogenicity of Diagnostic and Therapeutic, Invasive and Noninvasive Cardiovascular Interventions, Devices, and SurgeriesChapter 19. Iatrogenic Aspects of Noninvasive and Invasive Diagnostic Methods in Interventional Cardiology; Chapter 20. Iatrogenicity Associated With Interventional Treatment Modalities in Cardiology; Chapter 21. Iatrogenicity of Diagnostic and Therapeutic, Invasive and Noninvasive Cardiovascular Interventions, Devices, and Surgeries; Chapter 22. Iatrogenic Aspects of Cardiac Electrophysiology; Chapter 23. Iatrogenic Aspects in Cardiac Device Therapy
|
505 |
8 |
|
|a Chapter 24. Cardiovascular Iatrogenicity of Respiratory Therapeutic ModalitiesPart IV: Iatrogenic Aspects of Sport Cardiology and Lifestyle Modifications; Chapter 25. Trained Athletes; Chapter 26. Sports Cardiology; Chapter 27. Dangers of Lifestyle Modification Advice; Part V. Iatrogenicity of Dietary Supplements, Herbal Products, and Other Nontraditional Therapies in Cardiovascular Medicine; Chapter 28. Safety of Dietary and Herbal Supplements: Side Effects and Contraindications; Chapter 29. Interactions Between Supplements and Medications; Index
|
590 |
|
|
|a JSTOR
|b Books at JSTOR All Purchased
|
590 |
|
|
|a JSTOR
|b Books at JSTOR Evidence Based Acquisitions
|
590 |
|
|
|a JSTOR
|b Books at JSTOR Demand Driven Acquisitions (DDA)
|
650 |
|
0 |
|a Cardiovascular system
|x Diseases
|x Treatment.
|
650 |
|
0 |
|a Iatrogenic diseases.
|
650 |
|
2 |
|a Iatrogenic Disease
|
650 |
|
6 |
|a Appareil cardiovasculaire
|x Maladies
|x Traitement.
|
650 |
|
6 |
|a Maladies iatrogéniques.
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Public Health.
|2 bisacsh
|
650 |
|
7 |
|a Cardiovascular system
|x Diseases
|x Treatment.
|2 fast
|0 (OCoLC)fst00847218
|
650 |
|
7 |
|a Iatrogenic diseases.
|2 fast
|0 (OCoLC)fst00966438
|
700 |
1 |
|
|a Gussak, Ihor,
|e editor.
|
700 |
1 |
|
|a Kostis, John B.,
|e editor.
|
776 |
0 |
8 |
|i Print version:
|z 9780813586410
|
856 |
4 |
0 |
|u https://jstor.uam.elogim.com/stable/10.2307/j.ctt1q1cr8b
|z Texto completo
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL4789855
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 1455653
|
938 |
|
|
|a Project MUSE
|b MUSE
|n muse57922
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 15245802
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 15247127
|
994 |
|
|
|a 92
|b IZTAP
|